匈牙利批准使用中国产新冠疫苗

匈牙利政府药品监管机构1月29日批准使用中国国药集团研发的新冠疫苗，该国成为首个批准使用中国疫苗的欧盟成员国。匈牙利总理欧尔班表示，他最相信中国生产的新冠疫苗，个人会选择中国疫苗。

 

Hungary became the European Union's first member to approve China's Sinopharm COVID-19 vaccine¹, sealing a deal on Friday for 5 million doses just a week after becoming the first EU member to buy Russia's Sputnik V vaccine.

匈牙利成为首个批准使用中国国药集团新冠疫苗的欧盟成员国，并在1月29日与中方签订了购买500万剂疫苗的正式合同。就在一周前，匈牙利成为首个购买俄罗斯“卫星V”新冠疫苗的欧盟成员国。

 

Foreign Minister Peter Szijjarto said the Sinopharm vaccines² were enough to inoculate³ 2.5 million people, or about a quarter of its population, delivered in four batches⁴ over four months.

匈牙利外交部长彼得·西亚尔托说，中国国药集团研发的新冠疫苗将分4批在4个月内交付匈牙利，足够250万人接种，大约相当于匈牙利全国人口的四分之一。

 

Prime Minister Viktor Orban said he would personally opt⁵ to receive the Chinese vaccine, as he trusted it more than others.

匈牙利总理欧尔班表示，他最相信中国生产的新冠疫苗，个人会选择中国疫苗。

 

"I'm waiting for the Chinese vaccine, I trust in that the most," Orban said. "Some people think about vaccines ideologically⁶, and they need a western one and not an eastern one. I think the Chinese have known this virus for the longest, and they probably know it the best."

他说：“我在等待中国疫苗，也最相信中国疫苗。有人以意识形态思维认为应该用西方而不是东方的疫苗。我认为中国人是最早认识这个病毒的，他们也最了解这个病毒。”

 

Hungarian officials have criticised the EU for what they see as a slow vaccine roll-out, and in recent months have insisted that procuring⁷ vaccines developed in both western and eastern countries, such as Russia and China, would ensure that Hungarians get quick access to vaccinations⁸.

匈牙利官员批评欧盟在疫苗采购和分配问题上动作缓慢，并在近几个月坚称，采购俄罗斯和中国等国家研发的疫苗，不管是来自西方还是东方，这将确保匈牙利人能迅速接种疫苗。

 

The announcement came a day after Hungary's government issued a decree calling for a green light for any vaccine that had been administered to at least 1 million people in at least three other countries.

匈牙利政府在1月28日公布了一项法令，将对已经在至少3个其他国家接种百万以上人口的任何疫苗启动批准程序。

 

Millions of doses made by Sinopharm and Sinovac shipped around the world to developing countries, particularly in Asia and Latin America.

数百万剂中国国药集团和中国科兴生产的新冠疫苗被运往世界各地的发展中国家，尤其是在亚洲和拉丁美洲。

 

Meanwhile, EU countries, relying so far almost entirely⁹ on a vaccine from Pfizer, have fallen far behind Britain, the United States and a number of developing countries in rolling out vaccines.

与此同时，到目前为止几乎完全依赖辉瑞疫苗的欧盟国家，在疫苗接种方面已经远远落后于英国、美国和一些发展中国家。

 

Hungary's drug regulator gave emergency use approval to the Sinopharm vaccine, rather than wait for the bloc's European Medicines Agency (EMA) to give the go-ahead, adding it to a list that also includes the Pfizer, Moderna and AstraZeneca vaccines as well as Russia's Sputnik-V shot.

匈牙利药品监管机构并未等待欧洲药品管理局(EMA)的批准，而是批准紧急使用中国国药集团研发的新冠疫苗，并将其与辉瑞、摩德纳、阿斯利康以及俄罗斯“卫星V”等新冠疫苗一同列入紧急使用名单。

分享到：